GlassScriptPhysician profile
Catherine Kress
NPI 1326532607
$509.05
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $19.65 · 2022: $118 · 2023: $304 · 2024: $67.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $102.16 | 2022-2024 | |
| Novo Nordisk INC | $86.06 | 2022-2023 | Wegovy, Saxenda |
| Astellas Pharma US INC | $56.25 | 2023 | Veozah |
| Merck Sharp & Dohme LLC | $40.43 | 2021-2024 | Gardasil 9, Gardasil, Capvaxive |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.38 | 2023-2024 | Jardiance |
| Lilly USA, LLC | $36.25 | 2022-2023 | Mounjaro |
| Biohaven Pharmaceutical Holding Company LTD. | $27.67 | 2022 | |
| Abbvie INC. | $27.03 | 2023 | |
| Vbi Vaccine (Delaware) INC. | $24.84 | 2022 | |
| Hologic Sales and Service, LLC | $21.71 | 2023 | Aptima |
| Dynavax Technologies Corporation | $18.52 | 2023 | Heplisav-B |
| Organon LLC | $18.47 | 2022 | |
| Exact Sciences Corporation | $13.28 | 2023 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Kress listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.